Abstract Deadline Extended for CBS/CSPS/CC-CRS Conference
0 comments
by
Dear members and friends of the Canadian Biomaterials Society, The abstract deadline has been extended to March 2nd, 2026 for the upcoming CBS CCPS cc-CRS 2026 meeting this June in Vancouver, BC...
Dear friends , For this years annual meeting in beautiful Vancouver, BC June 2 - 5 2026 we are happy to partner with the Canadian Society for Pharmaceutical Sciences CSPS and the Canadian Chapter of the Controlled Release Society cc-CRS ...
Call for Abstracts for CBS/CSPS/cc-CRS Conference is now open!
0 comments
by
Call for Abstracts is OPEN The Canadian Biomaterials Society CBS , the Canadian Society for Pharmaceutical Sciences CSPS , and the Controlled Release Society cc-CRS are joining forces to host a landmark joint conference at UBC Vancouver...
Save the Date for CBS2026! June 2–5, 2026
0 comments
by
Overview The Canadian Biomaterials Society CBS , the Canadian Society for Pharmaceutical Sciences CSPS , and the Controlled Release Society cc-CRS are joining forces to host a landmark joint conference at UBC Vancouver...
Three-dimensional 3D bioprinting of photocrosslinkable hydrogels has attracted great interest for various tissue engineering applications as the biochemical and mechanical properties of the resulting hydrogel structures can be tuned to generate a physiologically relevant microenvironment for cells...
Adverse tissue reactions are the most common causes of implant failure, they can affect up to 40 of patients with Metal on Metal MoM implants in the first five years of implantation, and a lower but non-negligible number of Metal on Polyethylene MoP and Ceramic on Polyethylene implants 1 ...
Doxorubicin is widespread and influential apoptosis-inducing drug in cancer chemotherapy which interdicts DNA replication and treats different types of cancers including, benign, potentially-malignant, glioblastoma malignant tumours 1 2 3 ...
